Detalhe da pesquisa
1.
Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia.
Prostate
; 80(10): 731-741, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32356572
2.
Blocking GRP/GRP-R signaling decreases expression of androgen receptor splice variants and inhibits tumor growth in castration-resistant prostate cancer.
Transl Oncol
; 14(11): 101213, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34461557
3.
Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells In Vitro.
Mol Cancer Ther
; 20(2): 398-409, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33298586
4.
Human homolog of Drosophila Hairy and enhancer of split 1, Hes1, negatively regulates δ-catenin (CTNND2) expression in cooperation with E2F1 in prostate cancer.
Mol Cancer
; 9: 304, 2010 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21106062
5.
Characterization of cis elements of the probasin promoter necessary for prostate-specific gene expression.
Prostate
; 70(9): 934-51, 2010 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20209642
6.
Prostate epithelial cell fate.
Differentiation
; 76(6): 682-98, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18462434
7.
Activation of GRP/GRP-R signaling contributes to castration-resistant prostate cancer progression.
Oncotarget
; 7(38): 61955-61969, 2016 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27542219
8.
The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes.
Mol Endocrinol
; 17(8): 1484-507, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12750453
9.
SPARCL1 suppresses metastasis in prostate cancer.
Mol Oncol
; 7(6): 1019-30, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23916135
10.
The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.
Cancer Res
; 68(16): 6762-9, 2008 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18701501